Congratulations to Prof. Fanny Oliveira Arcolino, Prof. Niek van Til, and the Cure Lowe Foundation on receiving not one, but three prestigious awards to advance a new gene therapy approach for Lowe syndrome: the UMD Catalyst Grant, Biotech Booster, and EQT.

These awards will support critical early-stage research and the further development of a promising therapeutic strategy aimed at bringing new treatment possibilities to patients and families affected by this rare genetic condition.

This achievement represents an exciting new chapter in the Emma Children’s Hospital and Emma CPM research portfolio's and highlights the strength of collaboration between researchers, clinicians, patients, and industry partners.

A big congratulations to the entire team for this important milestone in the journey toward finding a cure for Lowe syndrome!